Epiregulin-loaded PLGA nanoparticles increase human keratinocytes proliferation: preliminary data

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Dermatology

Background:

• Epiregulin, an epidermal growth factor family member, is produced by keratinocytes.
• Keratinocyte proliferation is crucial for epithelial tissue repair and regeneration.
• Current treatments for conditions like gingival recession require enhanced epithelial growth.

Purpose of the Study:

• To investigate the efficacy of biocompatible nanoparticles loaded with epiregulin for enhancing human keratinocyte proliferation.
• To develop and characterize Poly-d,l-lactide-co-glycolide (PLGA) nanoparticles for targeted drug delivery.
• To assess the potential of epiregulin-loaded nanoparticles for periodontal applications.

Main Methods:

• Formulation and characterization of PLGA nanoparticles (NPs) with varying Poly lactic acid/Poly glycolic acid ratios using dynamic light scattering (DLS).
• Evaluation of NP adhesion to dental surfaces and epiregulin release kinetics via ELISA.
• Assessment of epiregulin-loaded NP effects on human keratinocyte proliferation in vitro.

Main Results:

• PLGA NPs exhibited varied size distributions based on the PLA/PGA ratio, with 50:50 formulations showing optimal size and dental adhesion.
• Epiregulin-loaded 50:50 PLGA NPs demonstrated successful epiregulin release and significantly increased human keratinocyte proliferation.
• The developed NPs showed potential for direct delivery to periodontal pockets.

Conclusions:

• 50:50 PLGA nanoparticles are a promising vehicle for delivering epiregulin to target sites due to their small size and adhesive properties.
• Epiregulin-loaded PLGA NPs can stimulate epithelial proliferation, offering a potential therapeutic strategy for periodontal disease and gingival recession.
• This study presents a novel approach for localized drug delivery in periodontal pockets, promoting tissue regeneration.